OVARIAN CANCER and US: Stanford

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label Stanford. Show all posts
Showing posts with label Stanford. Show all posts

Tuesday, March 27, 2012

Single antibody (CD47 ) shrinks variety of human tumors transplanted into mice, Stanford study shows | e! Science News



Single antibody shrinks variety of human tumors transplanted into mice, Stanford study shows | e! Science News

Human tumors transplanted into laboratory mice disappeared or shrank when scientists treated the animals with a single antibody, according to a new study from the Stanford University School of Medicine. The antibody works by masking a protein flag on cancer cells that protects them from macrophages and other cells in the immune system. The scientists achieved the findings with human breast, ovarian, colon, bladder, brain, liver and prostate cancer samples. It is the first antibody treatment shown to be broadly effective against a variety of human solid tumors, and the dramatic response -- including some overt cures in the laboratory animals -- has the investigators eager to begin phase-1 and -2 human clinical trials within the next two years.........

Wednesday, February 03, 2010

Stanford's Canary Center strives to find cancer sooner than every before - 2/01/10 - San Francisco News



"Scientists at the Canary Center say their first blood test, developed for ovarian cancer, is about to begin phase one clinical trials at Stanford. The first patient group will be women at high risk for ovarian cancer."